Franklin Resources
KYTX icon

Franklin Resources’s Kyverna Therapeutics KYTX Stock Holding History

Franklin Resources’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-677,587
Closed -$4.07M – 3296
2025
Q3 		$4.07M Sell
677,587
-17,440
-3% -$69.7K ﹤0.01% 1497
2025
Q2 		$2.13M Buy
695,027
+2,999
+0.4% +$7.42K ﹤0.01% 1688
2025
Q1 		$1.34M Hold
692,028
– – ﹤0.01% 1835
2024
Q4 		$2.59M Sell
692,028
-244,933
-26% -$1.17M ﹤0.01% 1642
2024
Q3 		$5.26M Buy
936,961
+113,922
+14% +$878K ﹤0.01% 1331
2024
Q2 		$6.17M Buy
823,039
+362,478
+79% +$5.54M ﹤0.01% 1247
2024
Q1 		$11.4M Buy
+460,561
New +$12.8M ﹤0.01% 1030

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Franklin Resources's KYTX Position: Q4 2025 in Review

Franklin Resources sold out of Kyverna Therapeutics (KYTX) in Q4 2025, closing a stake of 677,587 shares — an estimated $4.07M sold.

Franklin Resources first reported a position in KYTX in Q1 2024 and held it in 7 quarters. The position peaked at $11.4M in Q1 2024. 99 funds tracked by Wall St. Rank hold KYTX as of Q4 2025.

  • Franklin Resources reported no remaining Kyverna Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Franklin Resources sold 677,587 Kyverna Therapeutics shares in Q4 2025, an estimated $4.07M.
  • Franklin Resources first reported a position in Kyverna Therapeutics in Q1 2024 and held it in 7 quarters.
  • Franklin Resources's Kyverna Therapeutics position peaked at $11.4M in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q4 2025.

Based on Franklin Resources's 13F filing for Q4 2025, filed 11 Feb 2026.